EUR 0.08
(-1.89%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 10.51 Million EUR | 41.54% |
2022 | 7.43 Million EUR | 73.24% |
2021 | 4.29 Million EUR | 26.96% |
2020 | 3.37 Million EUR | -39.51% |
2019 | 5.58 Million EUR | -19.17% |
2018 | 6.91 Million EUR | -27.91% |
2017 | 9.58 Million EUR | 88.18% |
2016 | 5.09 Million EUR | -10.56% |
2015 | 5.69 Million EUR | 9.08% |
2014 | 5.22 Million EUR | -21.4% |
2013 | 6.64 Million EUR | 40.62% |
2012 | 4.72 Million EUR | 31.27% |
2011 | 3.59 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 6.53 Million EUR | 0.0% |
2023 Q4 | 5.33 Million EUR | 0.0% |
2023 Q2 | 5.43 Million EUR | 0.0% |
2023 FY | 10.51 Million EUR | 41.54% |
2022 Q2 | 3.11 Million EUR | 0.0% |
2022 FY | 7.43 Million EUR | 73.24% |
2022 Q4 | 4.31 Million EUR | 0.0% |
2021 FY | 4.29 Million EUR | 26.96% |
2021 Q2 | 1.88 Million EUR | 0.0% |
2021 Q4 | 2.4 Million EUR | 0.0% |
2020 Q4 | 1.95 Million EUR | 0.0% |
2020 FY | 3.37 Million EUR | -39.51% |
2020 Q2 | 1.42 Million EUR | 0.0% |
2019 Q2 | 2.74 Million EUR | 0.0% |
2019 Q4 | 2.39 Million EUR | 0.0% |
2019 FY | 5.58 Million EUR | -19.17% |
2018 Q2 | 3.58 Million EUR | 0.0% |
2018 FY | 6.91 Million EUR | -27.91% |
2018 Q4 | 3.32 Million EUR | 0.0% |
2017 Q2 | 6.21 Million EUR | 0.0% |
2017 FY | 9.58 Million EUR | 88.18% |
2017 Q4 | 3.37 Million EUR | 0.0% |
2016 Q2 | 2.67 Million EUR | 0.0% |
2016 FY | 5.09 Million EUR | -10.56% |
2016 Q4 | 2.41 Million EUR | 0.0% |
2015 FY | 5.69 Million EUR | 9.08% |
2015 Q4 | 2.92 Million EUR | 0.0% |
2015 Q2 | 2.76 Million EUR | 0.0% |
2014 Q4 | 2.62 Million EUR | 0.0% |
2014 Q2 | 2.59 Million EUR | 0.0% |
2014 FY | 5.22 Million EUR | -21.4% |
2013 FY | 6.64 Million EUR | 40.62% |
2013 Q4 | 3.59 Million EUR | 0.0% |
2013 Q2 | 3.04 Million EUR | 0.0% |
2012 Q1 | 1.38 Million EUR | 0.0% |
2012 Q2 | 1.38 Million EUR | 0.0% |
2012 Q3 | 1.38 Million EUR | 0.0% |
2012 Q4 | 1.66 Million EUR | 20.27% |
2012 FY | 4.72 Million EUR | 31.27% |
2011 Q3 | 938.95 Thousand EUR | 0.0% |
2011 Q4 | 1.38 Million EUR | 47.06% |
2011 FY | 3.59 Million EUR | 0.0% |
2011 Q1 | 938.95 Thousand EUR | 0.0% |
2011 Q2 | 938.95 Thousand EUR | 0.0% |
2010 Q4 | 938.95 Thousand EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Crossject Société Anonyme | 145 Thousand EUR | -7154.483% |
Safe Orthopaedics SA | 5.86 Million EUR | -79.474% |
Amplitude Surgical SA | 106.01 Million EUR | 90.078% |
Sartorius Stedim Biotech S.A. | 2.77 Billion EUR | 99.621% |
EssilorLuxottica Société anonyme | 25.39 Billion EUR | 99.959% |
bonyf N.V. | 309.37 Thousand EUR | -3300.092% |